ARCHIVES

Nexavar Improves PFS In Phase III Trial

This article is from The Cancer Letter archive.

Vol. 36 No. 1 | January 25, 2013

Download PDF Visit The Full Archive

Related Articles

NCI Needs 100 SBIR Contracts By April 1 To Avoid Losing $5 Million; NIH Objects To DCT Comments

March 22, 1985

AIDS Drug Discovery Groups RFA Draws 20 Applications

May 9, 1986

Scientists Defend NCI, Criticize Post Series As Inaccurate

November 20, 1981

More Clinical Trials Money Top Priority, DeVita Says; Drug Discovery Groups RFA Gets 12 Applications

February 24, 1984

Funding opportunities listed.

March 26, 2004

Obit: Same Shapiro, Proponent of Mammographic Screening.

January 7, 2000